Your browser is no longer supported. Please, upgrade your browser.
Settings
AB AllianceBernstein Holding L.P. daily Stock Chart
AB [NYSE]
AllianceBernstein Holding L.P.
Index- P/E10.93 EPS (ttm)2.15 Insider Own0.80% Shs Outstand95.64M Perf Week0.86%
Market Cap2.25B Forward P/E11.02 EPS next Y2.13 Insider Trans-25.50% Shs Float89.53M Perf Month12.17%
Income204.90M PEG4.08 EPS next Q0.45 Inst Own21.60% Short Float1.02% Perf Quarter8.29%
Sales227.90M P/S9.86 EPS this Y20.30% Inst Trans-15.83% Short Ratio1.79 Perf Half Y2.40%
Book/sh15.70 P/B1.50 EPS next Y6.76% ROA- Target Price24.93 Perf Year1.25%
Cash/sh0.00 P/C- EPS next 5Y2.68% ROE- 52W Range20.40 - 25.13 Perf YTD0.21%
Dividend1.98 P/FCF- EPS past 5Y34.90% ROI14.10% 52W High-6.47% Beta1.46
Dividend %8.43% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low15.20% ATR0.45
Employees3438 Current Ratio- Sales Q/Q-18.70% Oper. Margin- RSI (14)65.11 Volatility1.86% 2.13%
OptionableYes Debt/Eq0.00 EPS Q/Q-18.50% Profit Margin- Rel Volume0.46 Prev Close23.45
ShortableYes LT Debt/Eq0.00 EarningsJul 27 BMO Payout- Avg Volume508.81K Price23.50
Recom2.30 SMA202.74% SMA505.62% SMA2003.67% Volume234,455 Change0.21%
Jun-05-17Initiated Sidoti Buy $28
Apr-12-17Upgrade Keefe Bruyette Mkt Perform → Outperform
Dec-16-16Downgrade BofA/Merrill Buy → Underperform
Nov-22-16Downgrade Citigroup Buy → Neutral
Mar-15-16Upgrade BofA/Merrill Neutral → Buy
Oct-12-15Downgrade Keefe Bruyette Outperform → Mkt Perform
Oct-07-15Downgrade BofA/Merrill Buy → Neutral
Jun-08-15Initiated Goldman Neutral
Jun-03-15Initiated Credit Suisse Neutral $37
Oct-13-09Reiterated Credit Suisse Neutral $22 → $26
Aug-07-09Downgrade Credit Suisse Outperform → Neutral $20 → $22
May-15-09Initiated Stifel Nicolaus Hold
Apr-20-09Downgrade Keefe Bruyette Outperform → Mkt Perform $21
Mar-05-09Initiated Citigroup Hold
Sep-22-08Upgrade Keefe Bruyette Mkt Perform → Outperform $60 → $48
Apr-24-08Reiterated Deutsche Securities Buy $85 → $69
Oct-25-07Reiterated Deutsche Securities Buy $106 → $99
Jun-27-07Initiated Credit Suisse Outperform $105
Jun-12-07Reiterated Deutsche Securities Buy $104 → $106
Apr-12-07Initiated Deutsche Securities Buy $104
Jun-22-17 11:43AM  AB Science Presents Supportive Data from its Phase 3 Study in Severe Systemic Mastocytosis at the 22nd Congress of the European Hematology Association (EHA) GlobeNewswire
Jun-20-17 11:19AM  Taking Control of Your Bond Market Risk Harvest Exchange
11:15AM  How the Populist Wave Could Reshape Policy Harvest Exchange
Jun-12-17 04:03PM  AB Announces May 31, 2017 Assets Under Management PR Newswire
11:10AM  UK Election Result Compounds Brexit Uncertainty Harvest Exchange
Jun-09-17 08:34AM  BNC Bancorp (BNCN) in Focus: Stock Moves 5.2% Higher Zacks
Jun-06-17 09:39AM  Distenfeld Sees Combined Value in High Yield, Treasuries Bloomberg Video
Jun-02-17 10:16AM  Top Ranked Income Stocks to Buy for June 2nd Zacks
Jun-01-17 01:39PM  [$$] Adams Street Hires Staffer to Lead New Munich Office The Wall Street Journal
May-29-17 06:50AM  4 Reasons to Buy AllianceBernstein (AB) Stock Right Now Zacks
May-25-17 01:50PM  AB's Harting Says Emerging Markets Have More Gas in Tank Bloomberg Video
07:36AM  Behind Carlyles Distributions and Repurchases Market Realist
May-24-17 10:15AM  New Strong Buy Stocks for May 24th Zacks
08:58AM  What Falling Estimates & Price Mean for Medley Capital (MCC) Zacks
May-22-17 11:40AM  AllianceBernstein's Biggest Holder Saw Ex-CEO as Wrong Guy -- With Right Ideas TheStreet.com
10:18AM  New Strong Buy Stocks for May 22nd Zacks
09:15AM  Top Ranked Income Stocks to Buy for May 22nd Zacks
May-18-17 10:45AM  AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting GlobeNewswire
07:54AM  New Strong Buy Stocks for May 18th Zacks
07:00AM  AB's Shakeup Is a Reason to Pause, Not Panic Morningstar
May-17-17 01:14PM  AB Science announces that CHMP has adopted a negative opinion for masitinib in indolent systemic mastocytosis, primarily due to GCP inspection findings GlobeNewswire
May-16-17 01:20PM  What you need to know on Wall Street today Business Insider
10:35AM  Top Ranked Income Stocks to Buy for May 16th Zacks
09:34AM  A $500 billion investor developed 'cutting edge' technology, and now it's sharing it with rivals Business Insider
May-15-17 06:11PM  [$$] AllianceBernstein Is Selling Bond-Trading Software The Wall Street Journal
11:55AM  AB Science provides the summary of both conference calls held on May 12, 2017, following ANSM decision requesting suspension of masitinib clinical studies conducted in France by AB Science GlobeNewswire
07:46AM  [$$] How Big Are Mutual Funds Puerto Rico Losses? $5.4 Billion The Wall Street Journal
May-14-17 06:38PM  [$$] How Big Are Mutual Funds' Puerto Rico Losses? $5.4 Billion The Wall Street Journal
May-12-17 08:47AM  New Strong Buy Stocks for May 12th Zacks
May-11-17 09:10PM  AB Science announces that ANSM requested the temporary suspension of clinical studies conducted in France following deviations from Good Clinical Practice (GCP) standards GlobeNewswire
May-10-17 12:48PM  AllianceBernstein Parent AXA is Coming to America Barrons.com
09:30AM  Zacks.com featured highlights: Insight Enterprises, Molina Healthcare, Huntsman, Western Digital and AllianceBernstein Holding Zacks
08:45AM  Sweating the Asset Managers Bloomberg
08:20AM  [$$] AXA's U.S. IPO Looks Like the Start of a Long Goodbye The Wall Street Journal
07:58AM  AB Announces April 30, 2017 Assets Under Management PR Newswire
07:17AM  AXA plans to list U.S. insurance, asset management business in 2018 Reuters
05:58AM  [$$] French Insurer AXA to List U.S. Unit The Wall Street Journal
03:43AM  AXA Shares Jump After US IPO Plans Follow Ousting of AllianceBernstein's Peter Kraus TheStreet.com
01:21AM  AXA: US stake float will provide financial flexibility CNBC Videos
01:21AM  AXA: Intend to float a minority stake in US operations in... CNBC Videos
01:07AM  [$$] French Insurer AXA to List U.S. Unit The Wall Street Journal
May-09-17 09:22AM  Moody's: All is Well at AllianceBernstein Barrons.com
07:20AM  Top Ranked Income Stocks to Buy for May 9th Zacks
May-08-17 09:46AM  Is AllianceBernstein a Great Stock for Value Investors? Zacks
May-05-17 01:29PM  [$$] Seth Bernstein steps into the breach at AllianceBernstein Financial Times
09:30AM  The Zacks Analyst Blog Highlights: SP Plus, Leucadia National, DXC Technology, CSX and AllianceBernstein Holding Zacks
05:56AM  Top Ranked Income Stocks to Buy for May 5th Zacks
May-04-17 05:55PM  What Caused Kinrosss Stock to Surge after Its 1Q17 Results? Market Realist
05:11PM  5 Top Ranked Stocks to Buy on Services Sector Gains Zacks
01:12PM  AllianceBernstein Holding LP : AB-US: Dividend Analysis : May 08th, 2017 (record date) : By the numbers : May 4, 2017 Capital Cube
07:30AM  AXA Kills the Messenger Bloomberg
12:01AM  [$$] Uncertainty swirls over Axa's shake-up of AllianceBernstein Financial Times
May-03-17 10:23AM  Top Ranked Income Stocks to Buy for May 3rd Zacks
May-02-17 10:15AM  5 Top Dividend Picks to Cast Out Sell in May Spell Zacks
10:08AM  What is Going on at AllianceBernstein? Barrons.com
12:26AM  [$$] AllianceBernsteins CEO, Independent Directors Ousted The Wall Street Journal
12:24AM  [$$] An Awkward Embrace for AXA and AllianceBernstein The Wall Street Journal
May-01-17 07:08PM  PRESS DIGEST- Financial Times - May 2 Reuters
07:05PM  [$$] AllianceBernstein's CEO, Independent Directors Ousted The Wall Street Journal
05:28PM  [$$] AllianceBernstein Picks Longtime J.P. Morgan Executive as CEO The Wall Street Journal
05:25PM  [$$] An Awkward Embrace for AXA and AllianceBernstein The Wall Street Journal
02:39PM  AllianceBernstein parent abruptly removes CEO Kraus, directors Reuters
01:46PM  AllianceBernstein CEO Kraus Fired Along With All Independent Board Members TheStreet.com
01:44PM  [$$] Axa ousts AllianceBernstein chief Peter Kraus in shake-up Financial Times
01:02PM  AllianceBernstein abruptly removes CEO Kraus and directors Reuters
12:43PM  AllianceBernstein CEO Peter Kraus is Out! Barrons.com
11:27AM  AllianceBernstein fires CEO and nine board members CNBC Videos
08:15AM  Edited Transcript of AB earnings conference call or presentation 27-Apr-17 12:00pm GMT Thomson Reuters StreetEvents
07:39AM  AllianceBernstein Ousts Kraus, Removes Directors in Shake-Up Bloomberg
07:00AM  AB Appoints New Leadership - Names Robert B. Zoellick Chairman, Seth Bernstein CEO PR Newswire
02:46AM  AB Science reports today its annual financials as of 31 December 2016 and provides an update on its activities GlobeNewswire
Apr-28-17 09:45AM  ABs Zlotnikov Says U.S. Economic Growth Will Go Higher Bloomberg Video
09:32AM  Top Ranked Income Stocks to Buy for April 28th Zacks
Apr-27-17 09:28AM  AllianceBernstein posts 1Q profit Associated Press
06:53AM  AllianceBernstein Holding L.P. Announces First Quarter Results PR Newswire
Apr-13-17 11:51AM  AB to Report First Quarter 2017 Results on Thursday, April 27, 2017 PR Newswire
Apr-12-17 04:03PM  AB Announces March 31, 2017 Assets Under Management PR Newswire
11:05AM  Analysts' Actions -- Lululemon, L Brands, Masco, Under Armour and More TheStreet.com
09:24AM  Morning Movers: Delta, Lululemon, Pepsi On The Rise Barrons.com
Apr-05-17 07:35PM  US stocks will face a tougher year-end: Strategist
Mar-29-17 01:09PM  AB Science announces that masitinib study in primary and secondary progressive forms of multiple sclerosis has passed its non-futility test at 2 years GlobeNewswire
Mar-20-17 02:51AM  AB Science announces positive top-line results of final analysis from study AB10015 of masitinib in amyotrophic lateral sclerosis (ALS) GlobeNewswire
Mar-18-17 01:21AM  [$$] AllianceBernstein Fires the Latest Shot in Fee Wars Barrons.com
01:21AM  [$$] AllianceBernstein Fires the Latest Shot in Fee Wars at Barrons.com
Mar-09-17 05:03PM  ALLIANCEBERNSTEIN HOLDING L.P. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:04PM  AB Announces February 28, 2017 Assets Under Management PR Newswire
Mar-07-17 12:34PM  AB Science announces that Frontiers in Aging Neuroscience publishes a comprehensive review on the future potential of masitinib in amyotrophic lateral sclerosis (ALS) GlobeNewswire
Mar-06-17 01:56AM  AB Science : Phase 3 asthma fully enrolled GlobeNewswire
Feb-24-17 10:27AM  AB Expands Multi-Asset Solutions Platform with Industry Veteran New Hire PR Newswire
Feb-22-17 11:49AM  Peter S. Kraus, Chairman and CEO, to Participate in the 2017 Citi Asset Management, Broker Dealer & Market Structure Conference on March 1 PR Newswire
Feb-17-17 01:04PM  ALLIANCEBERNSTEIN HOLDING L.P. Financials
Feb-14-17 10:23PM  [$$] finance Watch The Wall Street Journal
10:23PM  [$$] finance Watch at The Wall Street Journal
02:58PM  [$$] New AllianceBernstein Funds Link Fees to Performance at The Wall Street Journal
09:33AM  Edited Transcript of AB earnings conference call or presentation 14-Feb-17 1:00pm GMT
08:00AM  AllianceBernstein Holding LP Earnings Call scheduled for 8:00 am ET today
07:20AM  ALLIANCEBERNSTEIN HOLDING L.P. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
07:07AM  Q4 2016 AllianceBernstein Holding LP Earnings Release - Before Market Open
07:06AM  AllianceBernstein posts 4Q profit
06:57AM  ALLIANCEBERNSTEIN HOLDING L.P. Files SEC form 10-K, Annual Report
AllianceBernstein Holding L.P. is publicly owned investment manager. The firm also provides research services to its clients. It provides its services to investment companies, pension and profit sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations, and other business entities. The firm invests in public equity, fixed income, and alternative investment markets across the globe. It employs long/short strategy to make its investments. The firm conducts in-house research to make its investments. AllianceBernstein Holding L.P. was founded in 1987 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gingrich James AChief Operating OfficerJun 22Option Exercise17.053,50059,675342,581Jun 22 04:35 PM
Gingrich James AChief Operating OfficerJun 22Sale23.257,000162,750339,081Jun 22 04:35 PM
Gingrich James AChief Operating OfficerJun 21Option Exercise17.053,50059,675346,081Jun 22 04:35 PM
Gingrich James AChief Operating OfficerJun 21Sale23.207,000162,400342,581Jun 22 04:35 PM
Gingrich James AChief Operating OfficerJun 20Option Exercise17.053,50059,675349,581Jun 22 04:35 PM
Gingrich James AChief Operating OfficerJun 20Sale22.957,000160,650346,081Jun 22 04:35 PM
Gingrich James AChief Operating OfficerJun 19Option Exercise17.053,50059,675353,081Jun 19 04:02 PM
Gingrich James AChief Operating OfficerJun 19Sale23.307,000163,100349,581Jun 19 04:02 PM
Gingrich James AChief Operating OfficerJun 16Option Exercise17.053,50059,675356,581Jun 19 04:02 PM
Gingrich James AChief Operating OfficerJun 16Sale23.007,000161,000353,081Jun 19 04:02 PM
Gingrich James AChief Operating OfficerJun 15Option Exercise17.053,50059,675360,081Jun 19 04:02 PM
Gingrich James AChief Operating OfficerJun 15Sale23.107,000161,700356,581Jun 19 04:02 PM
Gingrich James AChief Operating OfficerJun 14Option Exercise17.053,50059,675363,581Jun 14 04:10 PM
Gingrich James AChief Operating OfficerJun 14Sale23.107,000161,700360,081Jun 14 04:10 PM
Gingrich James AChief Operating OfficerJun 13Option Exercise17.053,50059,675367,081Jun 14 04:10 PM
Gingrich James AChief Operating OfficerJun 13Sale23.057,000161,350363,581Jun 14 04:10 PM
Gingrich James AChief Operating OfficerJun 12Option Exercise17.053,50059,675370,581Jun 14 04:10 PM
Gingrich James AChief Operating OfficerJun 12Sale23.107,000161,700367,081Jun 14 04:10 PM
Gingrich James AChief Operating OfficerJun 09Option Exercise17.053,50059,675374,081Jun 09 04:38 PM
Gingrich James AChief Operating OfficerJun 09Sale23.007,000161,000370,581Jun 09 04:38 PM
Gingrich James AChief Operating OfficerJun 08Option Exercise17.053,50059,675377,581Jun 09 04:38 PM
Gingrich James AChief Operating OfficerJun 08Sale22.937,000160,475374,081Jun 09 04:38 PM
FARRELL EDWARD JSVP and ControllerJun 08Sale23.1510,000231,50029,147Jun 09 04:37 PM
Gingrich James AChief Operating OfficerJun 07Option Exercise17.053,50059,675381,081Jun 09 04:38 PM
Gingrich James AChief Operating OfficerJun 07Sale22.887,000160,125377,581Jun 09 04:38 PM
Gingrich James AChief Operating OfficerJun 06Option Exercise17.051,75029,838382,831Jun 07 07:27 AM
Gingrich James AChief Operating OfficerJun 06Sale22.503,50078,750381,081Jun 07 07:27 AM
Gingrich James AChief Operating OfficerJun 05Option Exercise17.051,75029,838384,581Jun 07 07:27 AM
Gingrich James AChief Operating OfficerJun 05Sale22.753,50079,625382,831Jun 07 07:27 AM
Gingrich James AChief Operating OfficerJun 02Option Exercise17.051,75029,838386,331Jun 05 04:10 PM
Gingrich James AChief Operating OfficerJun 02Sale22.633,50079,188384,581Jun 05 04:10 PM
SLUTSKY LORIE AFormer DirectorJun 02Sale22.639,759220,84610,407Jun 05 08:36 AM
Gingrich James AChief Operating OfficerJun 01Option Exercise17.053,50059,675389,831Jun 05 04:10 PM
Gingrich James AChief Operating OfficerJun 01Sale22.787,000159,425386,331Jun 05 04:10 PM
Zoellick Robert B.Non-Exec. ChairmanMay 30Buy21.8511,300246,84931,300May 30 04:02 PM
ELLIOTT STEVEN GFormer DirectorMay 30Sale22.1815,627346,5790May 31 04:15 PM
Hechinger Deborah SFormer DirectorMay 24Sale21.057,814164,4850May 25 04:01 PM
SCHOEN SCOTT AFormer DirectorMay 22Sale20.9115,627326,6820May 23 07:20 AM
ELLIOTT STEVEN GFormer DirectorMay 19Option Exercise14.5816,349238,36831,976May 23 05:59 PM
ELLIOTT STEVEN GFormer DirectorMay 19Sale21.0816,349344,55515,627May 23 05:59 PM
Hechinger Deborah SFormer DirectorMay 17Sale21.0210,380218,1887,814May 18 05:15 PM
SCHOEN SCOTT ADirectorMay 15Sale21.2837,485797,68115,627May 15 06:45 PM
SCHOEN SCOTT ADirectorMay 12Sale21.0924,500516,70553,112May 15 06:45 PM
SLUTSKY LORIE AFormer DirectorMay 11Sale21.0112,663266,08820,166May 15 08:43 AM
ELLIOTT STEVEN GFormer DirectorMay 04Sale20.4911,414233,87315,627May 08 06:24 PM
HICKS WESTON MDirectorAug 04Sale21.504,53997,58926,469Aug 04 04:00 PM